Investor mix
10 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 50% |
| Private equity | 2 | 20% |
| Other / undisclosed | 3 | 30% |
Drug patent intelligence for strategic decisions on generic entry opportunities
10 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 50% |
| Private equity | 2 | 20% |
| Other / undisclosed | 3 | 30% |